These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 26383234)

  • 21. Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling.
    Hsu YC; Chen CT; Wei YH
    Biochim Biophys Acta; 2016 Apr; 1860(4):686-93. PubMed ID: 26779594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reprogramming mechanisms influence the maturation of hematopoietic progenitors from human pluripotent stem cells.
    Heo HR; Song H; Kim HR; Lee JE; Chung YG; Kim WJ; Yang SR; Kim KS; Chun T; Lee DR; Hong SH
    Cell Death Dis; 2018 Oct; 9(11):1090. PubMed ID: 30356076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of mass spectrometry-based proteomics in the study of cellular reprogramming and induced pluripotent stem cells.
    Benevento M; Munoz J
    Expert Rev Proteomics; 2012 Aug; 9(4):379-99. PubMed ID: 22967076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation.
    Yi L; Lu C; Hu W; Sun Y; Levine AJ
    Cancer Res; 2012 Nov; 72(21):5635-45. PubMed ID: 22964580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artd1/Parp1 regulates reprogramming by transcriptional regulation of Fgf4 via Sox2 ADP-ribosylation.
    Weber FA; Bartolomei G; Hottiger MO; Cinelli P
    Stem Cells; 2013 Nov; 31(11):2364-73. PubMed ID: 23939864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances.
    Chhabra A
    Stem Cell Rev Rep; 2017 Dec; 13(6):757-773. PubMed ID: 28918520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Divergent reprogramming routes lead to alternative stem-cell states.
    Tonge PD; Corso AJ; Monetti C; Hussein SM; Puri MC; Michael IP; Li M; Lee DS; Mar JC; Cloonan N; Wood DL; Gauthier ME; Korn O; Clancy JL; Preiss T; Grimmond SM; Shin JY; Seo JS; Wells CA; Rogers IM; Nagy A
    Nature; 2014 Dec; 516(7530):192-7. PubMed ID: 25503232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced Pluripotency and Epigenetic Reprogramming.
    Hochedlinger K; Jaenisch R
    Cold Spring Harb Perspect Biol; 2015 Dec; 7(12):. PubMed ID: 26626939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of pluripotency.
    Heffernan C; Liu J; Sumer H; Malaver-Ortega LF; Verma R; Carvalho E; Verma PJ
    Adv Exp Med Biol; 2013; 786():5-25. PubMed ID: 23696349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
    Kang L; Kou Z; Zhang Y; Gao S
    J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.
    Brix J; Zhou Y; Luo Y
    J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
    Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
    Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling?
    Yilmazer A; de Lázaro I; Taheri H
    Cancer Lett; 2015 Dec; 369(1):1-8. PubMed ID: 26276716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovine induced pluripotent stem cells are resistant to reprogramming after nuclear transfer.
    German SD; Campbell KH; Thornton E; McLachlan G; Sweetman D; Alberio R
    Cell Reprogram; 2015 Feb; 17(1):19-27. PubMed ID: 25513856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic aberrations in human pluripotent stem cells.
    Bar S; Benvenisty N
    EMBO J; 2019 Jun; 38(12):. PubMed ID: 31088843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear
    Chanda PK; Meng S; Lee J; Leung HE; Chen K; Cooke JP
    Circulation; 2019 Sep; 140(13):1081-1099. PubMed ID: 31412725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reprogramming somatic cells to pluripotency: a fresh look at Yamanaka's model.
    Li Y; Shen Z; Shelat H; Geng YJ
    Cell Cycle; 2013 Dec; 12(23):3594-8. PubMed ID: 24189530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced pluripotent stem cells: epigenetic memories and practical implications.
    Sullivan GJ; Bai Y; Fletcher J; Wilmut I
    Mol Hum Reprod; 2010 Dec; 16(12):880-5. PubMed ID: 21059705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.